Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? - Wikidata - awgldk - TriplyDB

Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?

Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?

http://www.wikidata.org/entity/Q24681087

about

sameAs

European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD Omega-3 fatty acids and depression: scientific evidence and biological mechanisms Bipolar disorder and mechanisms of action of mood stabilizers Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression Pharmacological interventions for self-harm in adults Omega-3 fatty acids for depression in adults Nutritional Cues Tie Living Organisms to Their Environment and Its Sustainability Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial.Differential effects of dietary oils on emotional and cognitive behaviors.Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial Exploratory multivariate analysis of the effect of fatty fish consumption and medicinal use on heart rate and heart rate variability data.Fatty acids and oxidative stress in psychiatric disorders.Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.Fish consumption and omega-3 polyunsaturated fatty acids in relation to depressive episodes: a cross-sectional analysis Coaching in healthy dietary practices in at-risk older adults: a case of indicated depression prevention The mothers, Omega-3 and mental health study.The effects of polyunsaturated fatty acids in alcohol dependence treatment--a double-blind, placebo-controlled pilot study.Depression as a disease of modernity: explanations for increasing prevalence.N-3 (omega-3) Fatty acids in postpartum depression: implications for prevention and treatment.Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.Controversies about a common etiology for eating and mood disorders.Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study.Clearance of fear memory from the hippocampus through neurogenesis by omega-3 fatty acids: a novel preventive strategy for posttraumatic stress disorder?Early life stress interacts with the diet deficiency of omega-3 fatty acids during the life course increasing the metabolic vulnerability in adult rats.Comparison of the Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on the Eradication of Helicobacter pylori Infection, Serum Inflammatory Factors and Total Antioxidant Capacity.Voluntary running in young adult mice reduces anxiety-like behavior and increases the accumulation of bioactive lipids in the cerebral cortex.Pathways of polyunsaturated fatty acid utilization: implications for brain function in neuropsychiatric health and disease.Transcriptomic analysis of the effects of a fish oil enriched diet on murine brains.Comparison of the Effects of Eicosapentaenoic Acid With Docosahexaenoic Acid on the Level of Serum Lipoproteins in Helicobacter pylori: A Randomized Clinical Trial FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation Greasing the wheels of managing overweight and obesity with omega-3 fatty acids.The global availability of n-3 fatty acids Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.Specific behavioral and cellular adaptations induced by chronic morphine are reduced by dietary omega-3 polyunsaturated fatty acids.Nutrition and depression at the forefront of progress Classical maple syrup urine disease and brain development: principles of management and formula design

P2860

Q21260332-56064B5E-EF1A-41B0-B50A-C68339AAFCB2 Q21284717-B9613E03-15C2-4256-BEF1-016CE8762483 Q22252332-124D4513-919C-4862-8794-5661BCF95F16 Q22305455-ACDA8649-CF3B-4556-AFC4-5957453B5EAE Q24186543-99F64BED-6C44-40E0-AB27-3905F6EFE779 Q24187951-794D6EEE-D913-462F-80BD-0EDD71B6F492 Q26738452-F9087292-4F20-47DE-8659-08F2F3E7F54B Q26740508-8B06441A-67D2-4F43-BF1D-CFC0B2FEF945 Q26741541-E2AFB476-7AAB-40CD-9BC6-AE3728BEB080 Q28703579-1CDDED8E-497F-4EA1-B8A8-761747BD915F Q30414969-9CF1768E-5296-4DAB-88B6-0E448A0D22E1 Q30478334-9B63E745-1717-490C-AC20-4005AFF53F61 Q30811539-F5F5EE04-B307-47D7-9CF9-EE6FB2BD39E1 Q30904046-73D1FED2-BB99-414D-8D73-1CF42FA31AD4 Q33330526-A12A04A5-E77D-44F9-B9EF-57A68B94CE16 Q33578486-EBB9656C-3C42-4E3C-A698-54A377924681 Q33580185-118E17AD-F444-4FFF-A270-EDFF698C1CE6 Q33852844-B84FF63D-6987-4D0D-907B-3E631CB63A33 Q33940207-FC813AAA-9458-4564-A8D7-6E71E0B42C12 Q33970586-2F5829FD-5BA0-4FA0-B7EE-7174876F79B4 Q34246950-7C2FB444-94BE-423E-A904-39C58B5ED93A Q34340306-048632B5-D21D-40A5-8A75-3BDA1839B709 Q34384181-149A0D33-694F-4C2D-A07C-8F67F461DD06 Q34406540-99D137F3-A54C-4791-8994-4C4D3010CA06 Q34555244-F9A6A721-EC05-424B-9C87-BD4640661096 Q34610802-93D2E0B1-9DB2-4F17-98FE-6F4A108DE8E8 Q34685518-CA4D1672-205A-4850-8C5C-7408FA95E19A Q34777760-59468723-CA50-41EA-A2C4-F4055741699F Q35069599-C6BEA391-08D1-4E39-B239-264A9F410E3B Q35117457-29BD751E-B974-4E5A-B1CC-3299551EA70E Q35121792-B3BCB0AA-3520-4165-BBDC-8676D30DCA0D Q35124311-3EF9962C-3521-4314-A582-81F00CE86586 Q35341972-6FC81935-24B0-4718-A26D-6E7C2247B1BA Q35534153-68A22AC7-7080-4353-8EA5-FC0231B4CBB9 Q35860882-B0A199EC-24B4-4228-B8D6-F302D306AA3F Q35928509-CF2B5989-2498-497C-BFF7-E1D4A05434C4 Q36217965-632B5217-2588-4A96-8DDD-D04866F46649 Q36336144-8F42914E-F473-4D89-947B-544676B38BB1 Q36517279-7C1085D5-FA01-4F1D-8FE2-105BA2A83930 Q36900927-EA1E414D-EF20-4245-96F5-584FA36B79AF

P2860

Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?

http://www.wikidata.org/entity/Q24681087

description

2007 nî lūn-bûn

@nan

2007 թուականին հրատարակուած գիտական յօդուած

@hyw

2007 թվականին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@ast

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@en

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@nl

type

label

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@ast

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@en

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@nl

prefLabel

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@ast

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@en

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@nl

P1433

Q24681087-46D9DDB5-0A41-41DD-9487-609F0402CEC2

P1476

Q24681087-ECA5D73E-1FA9-46C8-8A36-9B8344A279CA

P2093

Q24681087-32E33488-DE9E-4048-8637-C01F54C624E2

Q24681087-4C4A8877-019B-4FD9-822A-7B1533FDA814

Q24681087-C5F45C64-D258-4A3F-8DDA-3C5D60989DA2

P275

Q24681087-8E68D213-661B-4448-8F8C-7D2FA46B6C92

P2860

Q24681087-04E3A68E-15BE-414F-B1B8-ECAECEE67B84

Q24681087-056F7E07-884F-436A-860B-23B2D28A802B

Q24681087-091F4A94-1FE3-4E96-B7A2-B20E384480D5

Q24681087-09A18941-FF3F-4347-8FF6-D3AF993B857D

Q24681087-0CAA554A-DE19-4E8C-93C1-8668D4978F45

Q24681087-100A5380-8554-417B-BB27-1E2E5643703A

Q24681087-10A6CF26-E325-4E28-9A67-9E6B6828ECF5

Q24681087-111D12F8-2C2F-4490-98B8-D61CA7FB4C61

Q24681087-15C515AB-5D1F-4A2E-9BF9-EB43205DC3B1

Q24681087-1688D8D7-5E50-4347-8A93-E7E27790A414

P2888

Q24681087-2371DBC2-00A5-42ED-A96F-999F9DC0428F

P304

Q24681087-71BD1A90-605D-4524-A05C-091778A6FB96

P31

Q24681087-916BEF3E-3F46-4FB6-81D5-F511939A26BC

Q24681087-DBF710FF-3CCB-4DF1-929F-D7F2A20EA745

P3181

Q24681087-9BA2CE82-5C79-41E5-8F69-6AFA726ADA83

P356

Q24681087-D5877AF2-FF07-46C9-AB40-90C802FBF80E

P407

Q24681087-A99A1F67-A753-47EF-B69D-840721C33C7E

P433

Q24681087-B9C3BD18-C9F5-4EAA-8884-CA921A2E7146

P478

Q24681087-FD4494BC-01CA-4424-B9E8-2ACC74DEF307

P577

Q24681087-6E92334B-D798-4580-8272-4E60CC32FD71

Q24681087-7933018B-0292-4011-AD01-2AD5B4AFF7C9

P6179

Q24681087-D07D5179-F9F3-441E-9B47-969E541492F9

P698

Q24681087-DE76DCC4-10C1-4D1A-931A-C2D459B5D4DB

P921

Q24681087-6A31E180-6861-43C5-91E9-409B807A0729

Q24681087-927E8B24-528F-4867-BAEF-C47A49C95973

Q24681087-A6549A3E-1E85-435B-8322-7A6907D4BC23

Q24681087-ADC995B7-667A-4BFC-8471-5B08ACF19A2D

P932

Q24681087-F42B132B-1B80-45C8-9845-AC84E5B273AE

P3181

P356

P1433

Lipids in Health and Disease

P1476

Omega-3 fatty acids as treatme ...... disorder and which fatty acid?

@en

P2093

Brian M Ross

http://www.w3.org/2001/XMLSchema#string

Jennifer Seguin

http://www.w3.org/2001/XMLSchema#string

Lee E Sieswerda

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.0 Generic

P2860

Fatty acid metabolism in neurodevelopmental disorder: a new perspective on associations between attention-deficit/hyperactivity disorder, dyslexia, dyspraxia and the autistic spectrum

Polyunsaturated fatty acid supplementation for schizophrenia

Risperidone versus typical antipsychotic medication for schizophrenia

A rating scale for depression

An Inventory for Measuring Depression

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers

P2888

P304

21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3518052

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-511X-6-21

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2007-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1002225760

http://www.w3.org/2001/XMLSchema#string

P698

17877810

http://www.w3.org/2001/XMLSchema#string

P921

mental disorder

clinical chemistry

P932

2071911

http://www.w3.org/2001/XMLSchema#string